Exelixis, Inc. (EXEL)
NASDAQ: EXEL · Real-Time Price · USD
37.43
+0.22 (0.59%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Exelixis Market Cap

Exelixis has a market cap or net worth of $10.48 billion as of April 25, 2025. Its market cap has increased by 45.67% in one year.

Market Cap
10.48B
Enterprise Value
9.54B
1-Year Change
45.67%
Ranking
Category
Stock Price
$37.43

Market Cap Chart

Since April 17, 2000, Exelixis's market cap has increased from $630.80M to $10.48B, an increase of 1,560.74%. That is a compound annual growth rate of 11.88%.

History

DateMarket Cap% Change
Apr 24, 202510.41B9.51%
Dec 31, 20249.51B27.47%
Dec 29, 20237.46B44.19%
Dec 30, 20225.17B-10.54%
Dec 31, 20215.78B-7.11%
Dec 31, 20206.23B16.30%
Dec 31, 20195.35B-8.96%
Dec 31, 20185.88B-34.61%
Dec 29, 20178.99B110.58%
Dec 30, 20164.27B233.29%
Dec 31, 20151.28B355.89%
Dec 31, 2014281.10M-75.11%
Dec 31, 20131.13B34.59%
Dec 31, 2012839.00M36.62%
Dec 30, 2011614.10M-31.37%
Dec 31, 2010894.80M13.07%
Dec 31, 2009791.40M49.29%
Dec 31, 2008530.10M-41.23%
Dec 31, 2007902.00M4.64%
Dec 29, 2006862.00M10.08%
Dec 30, 2005783.10M10.19%
Dec 31, 2004710.70M41.83%
Dec 31, 2003501.10M9.05%
Dec 31, 2002459.50M-44.16%
Dec 31, 2001822.90M25.02%
View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 759.69B
UnitedHealth Group 388.43B
Johnson & Johnson 371.94B
AbbVie 316.42B
Novo Nordisk 276.62B
Abbott Laboratories 223.28B
AstraZeneca 213.42B
Novartis AG 208.99B
Market Cap Rankings